Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
However, all integrase inhibitors were associated with similar weight gain.
Switching to an integrase inhibitors is not tied to gain in bad fat, according to recent study.
Resistance to four HIV drug classes is tied to high risk of disease and death.
The antiretroviral drug class includes bictegravir, dolutegravir, elvitegravir and raltegravir.
A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.
This may reflect loss of the weight-suppressing effect of the older version of the drug.
HIV advocate Lepena Reid confronts weight gain.
Some HIV meds are linked to weight gain, but we don’t yet know why.
Aging with HIV won’t slow down Robert Gillum.
Researchers are surprised and concerned that a strain of HIV that is so broadly resistant to treatment even has the capacity to transmit.
Researchers looked at potential drug-drug interactions among Swiss people with HIV and compared them with a cohort from 2008.
People who switched from tenofovir disoproxil fumarate to tenofovir alafenamide gained weight regardless of other meds.
The agency has also lowered the weight threshold for film-coated tablets of the integrase inhibitor.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.